Sign in
4

Changes in Ownership

Tarsus Pharmaceuticals, Inc. Filed Acc 0001827672-23-000002

President/CEO and Board Chair sold 1,634 shares at an average $15.16 ($24,773)

From the SEC's structured data for this filing

Trades in this filing

Azamian Bobak R. · President/CEO and Board Chair

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-01-09 Sale : show line 1 in the form −729 $15.15 $11,044 1,129,422 I
2023-01-10 Sale : show line 2 in the form −905 $15.17 $13,729 1,128,517 I
Open-market sales · 1,634 sh · avg $15.16 · $24,773
Loading xslF345X03/wf-form4_167348676340762.xml…